Luedtke D[au] - Search Results

Year	Number of Results
1978	1
2010	1
2016	1
2017	3
2018	4
2019	1
2020	1
2021	1
2022	3
2024	0

1

Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignancies.

Keller KM, Krausert S, Gopisetty A, Luedtke D, Koster J, Schubert NA, Rodríguez A, van Hooff SR, Stichel D, Dolman MEM, Vassal G, Pfister SM, Caron HN, Stancato LF, Molenaar JJ, Jäger N, Kool M. Keller KM, et al. Among authors: luedtke d. Eur J Cancer. 2022 Feb;162:107-117. doi: 10.1016/j.ejca.2021.11.030. Epub 2021 Dec 25. Eur J Cancer. 2022. PMID: 34963094 Free article. Review.

2

A delicate balance - The BCL-2 family and its role in apoptosis, oncogenesis, and cancer therapeutics.

Knight T, Luedtke D, Edwards H, Taub JW, Ge Y. Knight T, et al. Among authors: luedtke d. Biochem Pharmacol. 2019 Apr;162:250-261. doi: 10.1016/j.bcp.2019.01.015. Epub 2019 Jan 19. Biochem Pharmacol. 2019. PMID: 30668936 Review.

3

Phase I studies of BI 1015550, a preferential phosphodiesterase 4B inhibitor, in healthy males and patients with idiopathic pulmonary fibrosis.

Maher TM, Schlecker C, Luedtke D, Bossert S, Zoz DF, Schultz A. Maher TM, et al. Among authors: luedtke d. ERJ Open Res. 2022 Oct 24;8(4):00240-2022. doi: 10.1183/23120541.00240-2022. eCollection 2022 Oct. ERJ Open Res. 2022. PMID: 36299369 Free PMC article.

4

Pharmacokinetics of Nintedanib in Subjects With Hepatic Impairment.

Marzin K, Kretschmar G, Luedtke D, Kraemer S, Kuelzer R, Schlenker-Herceg R, Schmid U, Schnell D, Dallinger C. Marzin K, et al. Among authors: luedtke d. J Clin Pharmacol. 2018 Mar;58(3):357-363. doi: 10.1002/jcph.1025. Epub 2017 Nov 6. J Clin Pharmacol. 2018. PMID: 29106740 Free PMC article. Clinical Trial.

5

Effects of Ketoconazole and Rifampicin on the Pharmacokinetics of Nintedanib in Healthy Subjects.

Luedtke D, Marzin K, Jungnik A, von Wangenheim U, Dallinger C. Luedtke D, et al. Eur J Drug Metab Pharmacokinet. 2018 Oct;43(5):533-541. doi: 10.1007/s13318-018-0467-9. Eur J Drug Metab Pharmacokinet. 2018. PMID: 29500603 Free PMC article. Clinical Trial.

6

Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumors.

Le Tourneau C, Becker H, Claus R, Elez E, Ricci F, Fritsch R, Silber Y, Hennequin A, Tabernero J, Jayadeva G, Luedtke D, He M, Isambert N. Le Tourneau C, et al. Among authors: luedtke d. ESMO Open. 2022 Oct;7(5):100576. doi: 10.1016/j.esmoop.2022.100576. Epub 2022 Sep 13. ESMO Open. 2022. PMID: 36108560 Free PMC article. Clinical Trial.

7

H₂O₂/Peroxynitrite-Activated Hydroxamic Acid HDAC Inhibitor Prodrugs Show Antileukemic Activities against AML Cells.

Liao Y, Xu L, Ou S, Edwards H, Luedtke D, Ge Y, Qin Z. Liao Y, et al. Among authors: luedtke d. ACS Med Chem Lett. 2018 Jun 13;9(7):635-640. doi: 10.1021/acsmedchemlett.8b00057. eCollection 2018 Jul 12. ACS Med Chem Lett. 2018. PMID: 30034592 Free PMC article.

8

Inhibition of XPO1 enhances cell death induced by ABT-199 in acute myeloid leukaemia via Mcl-1.

Luedtke DA, Su Y, Liu S, Edwards H, Wang Y, Lin H, Taub JW, Ge Y. Luedtke DA, et al. J Cell Mol Med. 2018 Dec;22(12):6099-6111. doi: 10.1111/jcmm.13886. Epub 2018 Sep 14. J Cell Mol Med. 2018. PMID: 30596398 Free PMC article.

9

Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia.

Luedtke DA, Su Y, Ma J, Li X, Buck SA, Edwards H, Polin L, Kushner J, Dzinic SH, White K, Lin H, Taub JW, Ge Y. Luedtke DA, et al. Signal Transduct Target Ther. 2020 Feb 26;5(1):17. doi: 10.1038/s41392-020-0112-3. Signal Transduct Target Ther. 2020. PMID: 32296028 Free PMC article.

10

Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells.

Luedtke DA, Niu X, Pan Y, Zhao J, Liu S, Edwards H, Chen K, Lin H, Taub JW, Ge Y. Luedtke DA, et al. Signal Transduct Target Ther. 2017 Apr 7;2:17012. doi: 10.1038/sigtrans.2017.12. eCollection 2017. Signal Transduct Target Ther. 2017. PMID: 29263915 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year